BACKGROUND. Malignant soft-tissue tumors often present substantial diagnostic challenges. Chromosome aberrations that might be diagnostic have been identified in some types of soft-tissue tumors, but the overall frequency and diagnostic relevance of these aberrations have not been established. METHODS. We attempted to determine the karyotypes of a series of 62 consecutive, unselected malignant spindle-cell or small round-cell soft-tissue tumors (from 46 adults and 16 children) after direct harvesting of cells or short-term culture. All tumors were examined independently by immunohistochemical staining in addition to routine light-microscopical evaluation, and all but two tumors were examined by electron microscopy. RESULTS. Metaphases were obtained from 61 of the 62 tumors, and clonal chromosome aberrations were identified in 55 (89 percent). In the six tumors that yielded metaphases but lacked apparent clonal aberrations, the normal metaphases were found to originate from non-neoplastic stromal elements within the tumor specimens. Thus, all tumors in which karyotyping was successful contained clonal chromosome aberrations. Forty of 62 tumors (65 percent) contained clonal chromosome aberrations that either suggested or confirmed a specific diagnosis; in 15 of these tumors (24 percent of all tumors), the aberrations were important in establishing the final diagnosis. Cytogenetic analyses were particularly informative about small round-cell tumors from children: 8 of 14 round-cell tumors contained diagnostically important chromosome aberrations. Using the combined approaches of light and electron microscopy, immunohistochemistry, and cytogenetics, we established an unambiguous diagnosis for 60 of 62 tumors. CONCLUSIONS. Cytogenetic analyses reveal clonal chromosome aberrations in virtually all malignant soft-tissue tumors. These clonal chromosome aberrations, particularly in small round-cell tumors in children, often have diagnostic relevance.
Source Information
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.
This article has been cited by other articles:
Skubitz, K. M., D'Adamo, D. R.
(2007). Sarcoma. Mayo Clin Proc.
82: 1409-1432
[Abstract][Full Text]
Janeway, K. A., Liegl, B., Harlow, A., Le, C., Perez-Atayde, A., Kozakewich, H., Corless, C. L., Heinrich, M. C., Fletcher, J. A.
(2007). Pediatric KIT Wild-Type and Platelet-Derived Growth Factor Receptor {alpha} Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors. Cancer Res.
67: 9084-9088
[Abstract][Full Text]
Miller, S. J., Rangwala, F., Williams, J., Ackerman, P., Kong, S., Jegga, A. G., Kaiser, S., Aronow, B. J., Frahm, S., Kluwe, L., Mautner, V., Upadhyaya, M., Muir, D., Wallace, M., Hagen, J., Quelle, D. E., Watson, M. A., Perry, A., Gutmann, D. H., Ratner, N.
(2006). Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.. Cancer Res.
66: 2584-2591
[Abstract][Full Text]
Li, F. P., Fletcher, J. A., Heinrich, M. C., Garber, J. E., Sallan, S. E., Curiel-Lewandrowski, C., Duensing, A., van de Rijn, M., Schnipper, L. E., Demetri, G. D.
(2005). Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred. JCO
23: 2735-2743
[Abstract][Full Text]
McArthur, G. A., Demetri, G. D., van Oosterom, A., Heinrich, M. C., Debiec-Rychter, M., Corless, C. L., Nikolova, Z., Dimitrijevic, S., Fletcher, J. A.
(2005). Molecular and Clinical Analysis of Locally Advanced Dermatofibrosarcoma Protuberans Treated With Imatinib: Imatinib Target Exploration Consortium Study B2225. JCO
23: 866-873
[Abstract][Full Text]
Oliveira, A. M., Hsi, B.-L., Weremowicz, S., Rosenberg, A. E., Cin, P. D., Joseph, N., Bridge, J. A., Perez-Atayde, A. R., Fletcher, J. A.
(2004). USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst. Cancer Res.
64: 1920-1923
[Abstract][Full Text]
Davis, I. J., Hsi, B.-L., Arroyo, J. D., Vargas, S. O., Yeh, Y. A., Motyckova, G., Valencia, P., Perez-Atayde, A. R., Argani, P., Ladanyi, M., Fletcher, J. A., Fisher, D. E.
(2003). Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc. Natl. Acad. Sci. USA
100: 6051-6056
[Abstract][Full Text]
French, C. A., Alexander, E. K., Cibas, E. S., Nose, V., Laguette, J., Faquin, W., Garber, J., Moore, F. Jr, Fletcher, J. A., Larsen, P. R., Kroll, T. G.
(2003). Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer. Am. J. Pathol.
162: 1053-1060
[Abstract][Full Text]
French, C. A., Miyoshi, I., Aster, J. C., Kubonishi, I., Kroll, T. G., Dal Cin, P., Vargas, S. O., Perez-Atayde, A. R., Fletcher, J. A.
(2001). BRD4 Bromodomain Gene Rearrangement in Aggressive Carcinoma with Translocation t(15;19). Am. J. Pathol.
159: 1987-1992
[Abstract][Full Text]
Steele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., Chadwick, R. B., de la Chapelle, A., Zhang, X.-k., Speleman, F., Huang, S.
(2001). Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev.
15: 2250-2262
[Abstract][Full Text]
MARQUES, M.A. M., ANTONIO, V.L., SARNO, E.N., BRENNAN, P.J., PESSOLANI, M.C. V.
(2001). Binding of {alpha}2-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells. J Med Microbiol
50: 23-28
[Abstract][Full Text]
Hibbard, M. K., Kozakewich, H. P., Cin, P. D., Sciot, R., Tan, X., Xiao, S., Fletcher, J. A.
(2000). PLAG1 Fusion Oncogenes in Lipoblastoma. Cancer Res.
60: 4869-4872
[Abstract][Full Text]
Danila, D. C., Zhang, X., Zhou, Y., Dickersin, G. R., Fletcher, J. A., Hedley-Whyte, E. T., Selig, M. K., Johnson, S. R., Klibanski, A.
(2000). A Human Pituitary Tumor-Derived Folliculostellate Cell Line. J. Clin. Endocrinol. Metab.
85: 1180-1187
[Abstract][Full Text]
Nielsen, G. P., Stemmer-Rachamimov, A. O., Ino, Y., Moller, M. B., Rosenberg, A. E., Louis, D. N.
(1999). Malignant Transformation of Neurofibromas in Neurofibromatosis 1 Is Associated with CDKN2A/p16 Inactivation. Am. J. Pathol.
155: 1879-1884
[Abstract][Full Text]
Angelov, L., Salhia, B., Roncari, L., McMahon, G., Guha, A.
(1999). Inhibition of Angiogenesis by Blocking Activation of the Vascular Endothelial Growth Factor Receptor 2 Leads to Decreased Growth of Neurogenic Sarcomas. Cancer Res.
59: 5536-5541
[Abstract][Full Text]
Rubin, B. P., Chen, C.-J., Morgan, T. W., Xiao, S., Grier, H. E., Kozakewich, H. P., Perez-Atayde, A. R., Fletcher, J. A.
(1998). Congenital Mesoblastic Nephroma t(12;15) Is Associated with ETV6-NTRK3 Gene Fusion : Cytogenetic and Molecular Relationship to Congenital (Infantile)Fibrosarcoma. Am. J. Pathol.
153: 1451-1458
[Abstract][Full Text]
Jones, D., Ballestas, M. E., Kaye, K. M., Gulizia, J. M., Winters, G. L., Fletcher, J., Scadden, D. T., Aster, J. C.
(1998). Primary-Effusion Lymphoma and Kaposi's Sarcoma in a Cardiac-Transplant Recipient. NEJM
339: 444-449
[Full Text]
Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., Spiegelman, B. M.
(1997). Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc. Natl. Acad. Sci. USA
94: 237-241
[Abstract][Full Text]
Jones, J. E., McGill, T.
(1995). Peripheral Primitive Neuroectodermal Tumors of the Head and Neck. Arch Otolaryngol Head Neck Surg
121: 1392-1395
[Abstract]
Singh, A. D., Husson, M., Shields, C. L., Potter, P. D., Shields, J. A.
(1994). Primitive Neuroectodermal Tumor of the Orbit. Arch Ophthalmol
112: 217-221
[Abstract]
Rowley, J. D., Aster, J. C., Sklar, J.
(1993). The Clinical Applications of New DNA Diagnostic Technology on the Management of Cancer Patients. JAMA
270: 2331-2337
[Abstract]
Previous
